Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group

Tissue Antigens

Volumn 60, Issue 3, 2002, Pages 224-234

  Swelsen, W T N ^a   Voorter, C E M ^a   Van den Berg Loonen, Ella M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B5 35 CREG; Exons 1 5; HLA B; Sequence based typing

Indexed keywords

HLA B ANTIGEN; HLA B35 ANTIGEN; HLA B5 ANTIGEN; UNCLASSIFIED DRUG; HLA B5; HLA-B5;

ALLELE; ANTIGEN SPECIFICITY; ARTICLE; CROSS REACTION; DNA POLYMORPHISM; EXON; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS;

ALLELES; BASE SEQUENCE; CROSS REACTIONS; EXONS; HLA-B ANTIGENS; HLA-B35 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 0036759861     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2002.600304.x     Document Type: Article

References (52)

1. Bodmer WF, Payne R. Theoretical consideration of leukocyte grouping using multi-specific antisera. In: Balner H, ed. Histocompatibility Testing. Copenhagen: Munksgaard, 1965: 141.
2. Dausset J. The workshop data, table III. In: Curtoni ES, Mattiuz PL, Tosi RM, eds. Histocompatibility Testing. Copenhagen: Munksgaard, 1967: 448.
3. Bodmer J. The A B C of HLA. A serological report of the 6th Histocompatibility Testing Workshop. In: Kissmeyer-Nielsen F, ed. Histocompatibility Testing. Copenhagen: Munksgaard, 1975: 21-69.
4. Hammond MG. Further Splits of HLA-B5. In: Terasaki PI, ed. Histocompatibility Testing. Los Angeles: University of California, 1980: 758.
5. Naik S, Mittall KK. Segregation of BW51, BW52, BW53, and BW35 in families: Splitting of BW51 into 'long' and 'short' variants. In: Terasaki PI, ed. Histocompatibility Testing. Los Angeles: University of California, 1980: 759.
6. Engelfriet CP, Veenhoven-Riesz von LE, Kort-Bakker M, Berg van den-Loonen PM. Some studies with anti-4C, anti-R, anti-HL-A5, anti-W5, W18 and the description of a new antigen of the four segregant series, called H.R. In: Dausset J, Colomboni J, eds. Histocompatibility Testing. Copenhagen: Munksgaard, 1972; 475-8.
7. Bodmer JG, Colombani J, Rocques P et al. Population studies. In: Dausset J, Colombani J, eds. Histocompatibility Testing. Copenhagen: Munksgaard, 1972: 621-67.
8. Zemmour J, Parham P. HLA class I nucleotide sequences, 1991. Hum Immunol 1991: 31: 195-206.
9. Albert ED, Mickey MR, McNicholas AC, Terasaki P. Serology and genetics of Te58 (W18) and other specificities included in the 4c complex. In: Terasaki P, ed. Histocompatibility Testing. Copenhagen: Munksgaard, 1970: 221.
10. Ooba T, Hayashi H, Karaki S, Tanabe M, Kano K, Takiguchi M. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 1989: 30: 76-80.
11. Hayashi H, Ennis PD, Ariga H et al. HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha-1 domain. J Immunol 1989: 142: 306-11.
12. Sekimata M, Hiraiwa M, Andrien M et al. Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA. J Immunol 1990: 144: 3228-33.
13. Hayashi H, Ooba T, Nakayama S, Sekimata M, Kano K, Takiguchi M. Allospecificities between HLA-Bw53 and HLA-B35 are generated by substitution of the residues associated with HLA-Bw4/Bw6 public epitopes. Immunogenetics 1990: 32: 195-9.
14. Kato N, Ward F, Kano K, Takiguchi M. Conservation of genes encoding HLA-B5 and B35 cross-reactive group antigens in various races. Hum Immunol 1992: 35: 253-5.
15. Hill AVS, Allsopp CEM, Kwiatkowski D et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991: 352: 595-600.
16. Ellis JM, Hoyer RJ, Costello CN et al. HLA-B allele frequencies in Cote d'Ivoire defined by direct DNA sequencing: Identification of HLA-B*1405, B*4410, and B*5302. Tissue Antigens 2001: 57: 339-43.
17. Anholts JDH, Kemps-Mols B, Verduijn W, Oudshoorn M, Schreuder GMTh. Three newly identified HLA-B alleles. B*5124, B*5306, B*5307 and confirmation of B*0809 and B*5606. Tissue Antigens 2001: 58: 38-41.
18. Steiner NK, Kosman C, Jones PF et al. Twenty-nine new HLA-B alleles associated with antigens in the 5C CREG. Tissue Antigens 2001: 57: 481-5.
19. Allsopp CEM, Harding RM, Taylor C et al. Interethnic genetic differentiation in Africa: HLA class I antigens in the Gambia. Am J Hum Genet 1992: 50: 411-21.
20. Madrigal JA, Belich MP, Hildebrand WH et al. Distinctive HLA-A, B antigens of black populations formed by interallelic conversion. J Immunol 1992: 149: 3411-5.
21. Prilliman K, Steiner N, Ellexson M et al. Novel alleles HLA-B*7802 and B*51022: Evidence for convergency in the HLA-B5 family. Tissue Antigens 1996: 47: 49-57.
22. Andrien M, Defleur V, Canck De I et al. B*78022, a new Caucasian member within the B78 family. Tissue Antigens 1997: 49: 79-83.
23. Gaidulis L, Krausa P, Schaub B, Senitzer D. Identification of a new HLA-B*78 allele in a Hispanic family. Tissue Antigens 2000: 56: 184-7.
24. Sekimoto T, Araseki M, Sato S, Sakaya S, Kato T, Ikeda H. Identification of a novel allele HLA-B*7805 in a Japanese female. Tissue Antigens 2001: 58: 345-8.
25. Voorter CEM, Vlies van der SA, Berg van den-Loonen EM. Sequence-based typing of HLA-B: The B7 cross-reacting group. Tissue Antigens 2000: 56: 356-62.
26. Vlies van der SA, Voorter CEM, Berg van den-Loonen EM. A reliable and efficient high resolution typing method for HLA-C using sequence-based typing. Tissue Antigens 1998: 52: 558-68.
27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988: 16: 1215.
28. Voorter CEM, Rozemuller EH, Bruyn de-Geraets D, Zwan van der AW, Tilanus MGJ, Berg van den-Loonen EM. Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 1997: 49: 471-6.
29. Voorter CEM, Bruyn de-Geraets D, Berg van den-Loonen EM. High-resolution HLA typing for the DRB3/4/5 genes by sequence-based typing. Tissue Antigens 1997: 50: 283-90.
30. Voorter CEM, Kik MC, Berg van den-Loonen EM. High-resolution HLA typing for the DQB1 gene by sequence-based typing. Tissue Antigens 1998: 51: 80-7.
31. Voorter CEM, Swelsen WTN, Berg van den-Loonen EM. Intron sequences of HLA-B*73. Tissue Antigens 2001: 57: 463-8.
32. Gomez-Casado E, Vargas-Alarcon G, Martinez Laso J et al. Generation of the HLA-B35-B5-B16, and B15 groups of alleles studied by intron 1 and 2 sequence analysis. Immunogenetics 1997: 46: 469-76.
33. Cereb N, Kong Y, Lee S, Maye P, Yang SY. Nucleotide sequences of MHC class I introns 1, 2, and 3 in humans and intron 2 in nonhuman primates. Tissue Antigens 1996: 47: 498-511.
34. Vlies van der SA, Voorter CEM, Berg van den-Loonen EM. There is more to HLA-C than exons 2 and 3: Sequencing of exons 1, 4 and 5. Tissue Antigens 1999: 54: 169-77.
35. Robinson J, Malik A, Parham P, Bodmer JG, Marsh SGE. IMGT/HLA database - A sequence database for the human major histocompatibility complex. Tissue Antigens 2000: 55: 280-7.
36. Braud V, Jones EY, McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 1997: 27: 1164-9.
37. Braud VM, Allan DSJ, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998: 391: 795-9.
38. Parham P, Adams EJ, Arnett KL. The origins of HLA-A, B, C polymorphism. Immunol Rev 1995: 143: 141-80.
39. Salter RD, Norment AM, Chen BP et al. Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature 1989: 338: 345-7.
40. Wesley PK, Clayberger C, Lyu S, Krensky AM. The CD8 coreceptor interaction with the alpha 3 domain of HLA class I is critical to the differentiation of human cytotoxic T-lymphocytes specific for HLA-A2 and HLA-Cw4. Hum Immunol 1993: 36: 149-55.
41. Fayen J, Huang J-H, Meyerson H et al. Class I MHC alpha 3 domain can function as an independent structural unit to bind CD8 alpha. Mol Immunol 1995: 32: 267-75.
42. Salter RD, Benjamin RJ, Wesley PK et al. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 1990: 345: 41-6.
43. Connolly JM, Hansenn TH, Ingold AL, Potter TA. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc Natl Acad Sci U S A 1990: 87: 2137-41.
44. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987: 329: 506-12.
45. Solheim JC. Class I MHC molecules: Assembly and antigen presentation. Immunol Rev 1999: 172: 11-9.
46. Hebert AM, Strohmaier J, Whitman MC et al. Kinetics and thermodynamics of beta-2 microglobulin binding to the alpha 3 domain of major histocompatibility complex class I heavy chain. Biochemistry 2001: 40: 5233-42.
47. Salter RD. Mutant HLA-A201 heavy chains with lowered affinity for beta2m are transported after growth at reduced temperatures. Hum Immunol 1992: 35: 40-9.
48. Osborn CK, Grigoriev V, Crew MD. Modulation of class I major histocompatibility complex antigen cell-surface stability by transmembrane domain length variation. Mol Immunol 1997: 34: 771-80.
49. Marsh SG, Bodmer JG, Albert ED et al. Nomenclature for factors of the HLA system, 2000. Tissue Antigens 2001: 57: 236-83.
50. Yao Z, Volgger A, Scholz S, Albert ED. Sequence polymorphism in the HLA-B promoter region. Immunogenetics 1995: 41: 343-53.
51. Summers CW, Hampson VJ, Taylor GM. HLA class I non-coding nucleotide sequences, 1992. Eur J Immunogenet 1993: 20: 201-40.
52. Cereb N, Yang SY. Dimorphic primers derived from intron 1 for use in the molecular typing of HLA-B alleles. Tissue Antigens 1997: 50: 74-6.